TERMINUS TRILOGY · BOOK 1 · WEAPONS SYSTEMS REFERENCE

Terminus Virus Biological · Class Extinction

Sa-engineered chimeric pandemic agent · Common designation: Red Eye Virus


Sa Designation
Terminus Virus
Human Designation
Red Eye Virus
Structural Class
Chimeric enveloped ssRNA pathogen
Base Architecture
Coronavirus (novel spike proteins; prior vaccines ineffective)
Secondary Mechanism
Retroviridae integration (HIV-class): reverse transcriptase + integrase; proviral DNA inserted into host chromosome
Behavioral Vector
Oxytocin neuropeptide upregulation: progressive elevation drives physical intimacy during asymptomatic shedding
Latency Period
6 to 8 weeks (asymptomatic; continuous shedding; immune system blind to integrated provirus)
Timer Mechanism
Telomere-like sequences at proviral termini erode through cell division; threshold breach triggers fulminant activation
Terminal Indicator
Bilateral conjunctival erythema (Red Eye): pathognomonic sign of imminent death
Time to Death (post-Red Eye)
24 to 72 hours
Target Lethality
~80% of global human population
HumanSo Effect
No lethality; G-series companion state [classified modification; see Book 1]
Origin
Sa Weapons Development · Deployed at global transit hubs for simultaneous multi-continental seeding
Terminus Virus: Virion Cross-Section
chimeric enveloped ssRNA architecture · annotated structural components · not to scale
S Protein Spike novel receptor-binding domain prior vaccines: ineffective Lipid Envelope host-derived; acquired at cell exit Matrix Layer structural protein shell Viral RNA Genome ss(+)RNA; retroviral component enables chromosomal integration Receptor-Binding Domain RBD head; enhanced host-cell affinity redesigned from coronavirus base Reverse Transcriptase HIV-class; transcribes viral RNA to DNA for chromosomal insertion Integrase splices proviral DNA into host chromosome; immune system blind Telomere Timer Sequences erode through cell division cycles threshold breach triggers Red Eye
Cross-section schematic · not to scale · internal components shown in exposed quarter-section view

Infection Timeline
three-phase progression from initial exposure to terminal outcome · asymptomatic shedding throughout latency
LATENCY PHASE 6 to 8 weeks asymptomatic · continuous shedding PRODROMAL Days 1 to 3 inflammation peaks TERMINAL Hours 0 to 72 Red Eye onset oxytocin elevation (behavioral transmission amplifier) EXPOSURE DEATH intestinal hemorrhage hematemesis · respiratory failure neurological deterioration
Infection timeline is schematic · latency duration: 6 to 8 weeks · terminal phase initiates at bilateral conjunctival erythema (Red Eye)
This is a virus that spreads through human warmth, through oxytocin, through the desire to touch and hold and be close to people you love. The Terminus Virus exploits every biological imperative toward human connection: the latency phase is not a flaw in its design but a feature. Infected hosts, chemically compelled toward intimacy, become asymptomatic vectors for six to eight weeks before the telomere timer sequences erode past threshold and the provirus activates. There is no visible carrier. There is no behavior to avoid. The virus weaponizes love itself. Specifications compiled from Terminus (Book 1) manuscript. ZenSa modification and HumanSo differential effect: classified; refer to Book 1.